170 related articles for article (PubMed ID: 33171140)
21. Amygdala Arginine Vasopressin Modulates Chronic Ethanol Withdrawal Anxiety-Like Behavior in the Social Interaction Task.
Harper KM; Knapp DJ; Butler RK; Cook CA; Criswell HE; Stuber GD; Breese GR
Alcohol Clin Exp Res; 2019 Oct; 43(10):2134-2143. PubMed ID: 31386210
[TBL] [Abstract][Full Text] [Related]
22. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
Trent NL; Menard JL
Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
[TBL] [Abstract][Full Text] [Related]
23. Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice.
Sparta DR; Fee JR; Hayes DM; Knapp DJ; MacNeil DJ; Thiele TE
Alcohol Clin Exp Res; 2004 Sep; 28(9):1324-30. PubMed ID: 15365302
[TBL] [Abstract][Full Text] [Related]
24. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
Lach G; de Lima TC
Neurobiol Learn Mem; 2013 Jul; 103():26-33. PubMed ID: 23603424
[TBL] [Abstract][Full Text] [Related]
25. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Gicquiaux H; Tschöpl M; Doods HN; Bucher B
Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
[TBL] [Abstract][Full Text] [Related]
26. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors.
Primeaux SD; Wilson SP; Cusick MC; York DA; Wilson MA
Neuropsychopharmacology; 2005 Sep; 30(9):1589-97. PubMed ID: 15770236
[TBL] [Abstract][Full Text] [Related]
27. Noradrenaline microinjected into the dorsal periaqueductal gray matter causes anxiolytic-like effects in rats tested in the elevated T-maze.
Estrada VB; Matsubara NK; Gomes MV; Corrêa FM; Pelosi GG
Life Sci; 2016 May; 152():94-8. PubMed ID: 26968783
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats.
Kask A; Kivastik T; Rägo L; Harro J
Prog Neuropsychopharmacol Biol Psychiatry; 1999 May; 23(4):705-11. PubMed ID: 10390728
[TBL] [Abstract][Full Text] [Related]
30. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.
Sajdyk TJ; Schober DA; Gehlert DR
Neuropharmacology; 2002 Dec; 43(7):1165-72. PubMed ID: 12504923
[TBL] [Abstract][Full Text] [Related]
32. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
33. Experimental protocol for detecting higher alcohol consumers from a conventional rat line based on basal anxiety.
Vázquez-León P; Miranda-Páez A; Marichal-Cancino BA
MethodsX; 2021; 8():101444. PubMed ID: 34434856
[TBL] [Abstract][Full Text] [Related]
34. Anti-nociceptive effect of neuropeptide Y in periaqueductal grey in rats with inflammation.
Wang JZ; Lundeberg T; Yu LC
Brain Res; 2001 Mar; 893(1-2):264-7. PubMed ID: 11223015
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety.
Kask A; Nguyen HP; Pabst R; Von Hörsten S
Neuroscience; 2001; 104(3):799-806. PubMed ID: 11440811
[TBL] [Abstract][Full Text] [Related]
36. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
37. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Trent NL; Menard JL
Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501
[TBL] [Abstract][Full Text] [Related]
38. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
[TBL] [Abstract][Full Text] [Related]
40. Involvement of amygdaloid neuropeptide Y in the anxiolytic effects of acupuncture during ethanol withdrawal in rats.
Zhao Z; Kim SC; Wu Y; Zhang J; Xu Y; Cho IJ; Yang CH; Lee BH; Zhao R
Neurosci Lett; 2014 May; 567():19-23. PubMed ID: 24674772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
